Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans

Phase: N/A Priority: Normal
NCT ID: NCT04461015 Org: User:
Start: 10/14/20 End: 01/06/22 Due: 01/06/23

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

Phase: N/A Priority: Normal
NCT ID: NCT05499702 Org: User:
Start: 12/15/22 End: 12/31/26 Due: 12/31/27

The Effects of Glucagon on Hepatic Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT05500586 Org: User:
Start: 10/20/22 End: 12/31/25 Due: 12/31/26

The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass

Phase: N/A Priority: Normal
NCT ID: NCT01843855 Org: User:
Start: 06/30/11 End: 09/30/13 Due: 09/30/14

Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04466618 Org: User:
Start: 04/15/21 End: 12/31/22 Due: 12/31/23

A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics

Phase: N/A Priority: Normal
NCT ID: NCT04466566 Org: User:
Start: 10/17/22 End: 12/31/25 Due: 12/31/26

A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Secretion

Phase: N/A Priority: Normal
NCT ID: NCT04459338 Org: User:
Start: 03/04/21 End: 06/14/22 Due: 06/14/23

The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass

Phase: N/A Priority: Normal
NCT ID: NCT01843881 Org: User:
Start: 03/31/12 End: 12/31/13 Due: 12/31/14

Dose-response Study of Exendin-9,39 on Glucose Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT01218633 Org: User:
Start: 05/31/11 End: 12/31/12 Due: 12/31/13